Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA): Notes Patent Potential Oct 17, 2025 07:21AM
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $29 at Cantor Fitzgerald Jul 10, 2025 07:17AM
Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA) Mar 12, 2025 06:55AM
Zevra Therapeutics (ZVRA) Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million Feb 27, 2025 07:37AM
Zevra Therapeutics (ZVRA) Prices 9.23M Share Offering at $6.50/sh Aug 9, 2024 06:20AM


Aug 9, 2024 12:00AM Zevra Therapeutics Announces Pricing of Underwritten Offering of Common Stock
Aug 8, 2024 04:01PM Zevra Therapeutics (ZVRA) Announces Proposed Share Offering
Aug 8, 2024 04:01PM Zevra Therapeutics Announces Proposed Public Offering of Common Stock
Jun 10, 2024 12:24PM Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA)